Catimanan, Rizal -.

HRN: 26-38-72  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2024
CEFUROXIME 750MG (VIAL)
12/16/2024
12/23/2024
IV
140mg
Q8H
PCAP C
Waiting Final Action 
12/16/2024
CEFTRIAXONE 1G (VIAL)
12/16/2024
12/22/2024
IV
440mg
OD
PCAP C
Waiting Final Action 
12/18/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
12/18/2024
12/25/2024
PO
1.5 Ml
Q 12
PCAP-C
Waiting Final Action 
12/23/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/23/2024
12/29/2024
IV
220 Mg
Q6H
PCAP C
Waiting Final Action 
01/13/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/13/2025
01/20/2025
IV
240
Q6
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: